SILVER SPRING, Md., June 24, 2021 /PRNewswire/ --
Today, The U.S. Food and Drug Administration Issued an Emergency Use Authorization (EUA) For The Drug Actemra ( Tocilizumab ) For The Treatment of Hospitalised Adults and Pediatric Patients ( 2 Years of Age and Older ) Who Are Receiving Systemic Corticosteroids and Require Supplemental Oxygen, Non-Invasive or Invasive Mechanical Ventilation, or Extracorporeal Membrane Oxygenation (ECMO) .
...